Summit Asset Management LLC purchased a new stake in Stereotaxis Inc (OTCMKTS:STXS) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 11,500 shares of the medical equipment provider’s stock, valued at approximately $40,000.
Separately, CWM LLC acquired a new position in Stereotaxis in the 3rd quarter valued at approximately $264,000. 20.75% of the stock is currently owned by hedge funds and other institutional investors.
OTCMKTS STXS traded down $0.20 on Tuesday, hitting $3.38. The company’s stock had a trading volume of 93,300 shares, compared to its average volume of 91,019. Stereotaxis Inc has a 1-year low of $1.01 and a 1-year high of $4.75. The company’s 50-day moving average is $3.54 and its 200 day moving average is $2.86.
Stereotaxis, Inc designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic system that enables physicians to complete interventional procedures by providing image guided delivery of catheters and guide wires through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures.
Read More: High-Yield Dividend Stocks
Want to see what other hedge funds are holding STXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stereotaxis Inc (OTCMKTS:STXS).
Receive News & Ratings for Stereotaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stereotaxis and related companies with MarketBeat.com's FREE daily email newsletter.